Amputees merge with their bionic leg

October 02, 2019

Djurica Resanovic lost his leg in a motorbike accident several years ago which resulted in amputation above the knee. Thanks to novel neuroprosthetic leg technology, Resanovic was successfully merged with his bionic leg during clinical trials in Belgrade, Serbia.

"After all of these years, I could feel my leg and my foot again, as if it were my own leg," reports Resanovic about the bionic leg prototype. "It was very interesting. You don't need to concentrate to walk, you can just look forward and step. You don't need to look at where your leg is to avoid falling."

Walking with instinct again

Scientists from a European consortium led by Swiss Institutions, ETH Zurich and EPFL spin-off SensArs Neuroprosthetics, with clinical trials in collaboration with institutions in Belgrade, Serbia, successfully characterized and implemented bionic leg technology with three amputees. The results appear in today's issue of Science Translational Medicine.

"We showed that less mental effort is needed to control the bionic leg because the amputee feels as though their prosthetic limb belongs to their own body," explains Stanisa Raspopovic, ETH Zurich professor and co-founder of EPFL spin-off SensArs Neuroprosthetics, who led the study.

He continues, "This is the first prosthesis in the world for above-knee leg amputees equipped with sensory feedback. We show that the feedback is crucial for relieving the mental burden of wearing a prosthetic limb which, in turn, leads to improved performance and ease of use."

Wearing a blindfold and earplugs, Resanovic could feel his/her bionic leg prototype thanks to sensory information that was delivered wirelessly via electrodes surgically placed into the stumps' intact nervous system. These electrodes pierce through the intact tibial nerve instead of wrapping around it. This approach has already proven to be efficient for studies of the bionic hand led by Silvestro Micera, co-author of the publication, EPFL's Bertarelli Foundation Chair in Translational Neuroengineering, professor of Bioelectronics at Scuola Superiore Sant'Anna, and co-founder of SensArs Neuroprosthetics. [See "How the bionic leg works: connection between body and machine".]

Resanovic continues, "I could tell when they touched the [big toe], the heel, or anywhere else on the foot. I could even tell how much the knee was flexed."

Resanovic is one of three leg amputees, all with transfemoral amputation, who participated in a three-month clinical study to test new bionic leg technology which literally takes neuroengineering a step forward, providing a promising new solution for this highly disabling condition that affects more than 4 million people in Europe and in the United-States.

Thanks to detailed sensations from sole of the artificial foot and from the artificial knee, all three patients could maneuver through obstacles without the burden of looking at their artificial limb as they walked. They could stumble over objects yet mitigate falling. Most importantly, brain imaging and psychophysical tests confirmed that the brain is less solicited with the bionic leg, leaving more mental capacity available to successfully complete the various tasks.

These results complement a recent study that demonstrated the clinical benefits of the bionic technology, like reducing phantom limb pain and fatigue.

Bionic leg: from prototype to product

"We develop the sensory feedback technology to augment prosthetic devices," explains Francesco Petrini, CEO and co-founder of SensArs Neuroprosthetics, and who is guiding an effort to bring these technologies to market. "An investigation longer than 3 months, with more subjects, and with in-home assessment, should be executed to provide more robust data to draw clinically significant conclusions about an improvement of the health and quality of life of patients." This project was funded in part by the NCCR Robotics and by the Bertarelli Foundation.

-- How the bionic leg works: connection between body and machine

The fundamental neuroengineering principle is about merging body and machine. It involves imitating the electrical signals that the nervous system would have normally received from the person's own, real leg. Specifically, the bionic leg prototype is equipped with 7 sensors all along the sole of the foot and 1 encoder at the knee that detects the angle of flexion. These sensors generate information about touch and movement from the prosthesis. Next, the raw signals are engineered via a smart algorithm into biosignals which are delivered into the stump's nervous system, into the tibial nerve via intraneural electrodes, and these signals reach the brain for interpretation.

Intraneural electrodes are key for neuroprosthetics

"We believe intraneural electrodes are key for delivering bio-compatible information to the nervous system for a vast number of neuroprosthetic applications. Translation to the market is just around the corner", explains Silvestro Micera, co-author of the publication, EPFL's Bertarelli Foundation Chair in Translational Neuroengineering, professor of Bioelectronics at Scuola Superiore Sant'Anna, and co-founder of SensArs Neuroprosthetics. Micera continues to innovate in the field of translational neuroscience using intraneural electrodes, like the bionic hand, optic nerve stimulation, and vagus nerve stimulation for heart-transplant patients..
-end-


Ecole Polytechnique Fédérale de Lausanne

Related Clinical Trials Articles from Brightsurf:

Nearly 1 in 5 cancer patients less likely to enroll in clinical trials during pandemic
A significant portion of cancer patients may be less likely to enroll in a clinical trial due to the ongoing coronavirus pandemic.

COVID-19 clinical trials lack diversity
Despite disproportionately higher rates of COVID-19 infection, hospitalization and death among people of color, minority groups are significantly underrepresented in COVID-19 clinical trials.

Why we should trust registered clinical trials
In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study brings good news about the credibility of registered clinical trials.

Inclusion of children in clinical trials of treatments for COVID-19
This Viewpoint discusses the exclusion of children from coronavirus disease 2019 (COVID-19) clinical trials and why that could harm treatment options for children.

Review evaluates how AI could boost the success of clinical trials
In a review publishing July 17, 2019 in the journal Trends in Pharmacological Sciences, researchers examined how artificial intelligence (AI) could affect drug development in the coming decade.

Kidney patients are neglected in clinical trials
The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients.

Clinical trials beginning for possible preeclampsia treatment
For over 20 years, a team of researchers at Lund University has worked on developing a drug against preeclampsia -- a serious disorder which annually affects around 9 million pregnant women worldwide and is one of the main causes of death in both mothers and unborn babies.

Underenrollment in clinical trials: Patients not the problem
The authors of the study published this month in the Journal of Clinical Oncology investigated why many cancer clinical trials fail to enroll enough patients.

When designing clinical trials for huntington's disease, first ask the experts
Progress in understanding the genetic mutation responsible for Huntington's disease (HD) and at least some molecular underpinnings of the disease has resulted in a new era of clinical testing of potential treatments.

New ALS therapy in clinical trials
New research led by Washington University School of Medicine in St.

Read More: Clinical Trials News and Clinical Trials Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.